Home/Filings/4/0001225208-22-001307
4//SEC Filing

Meredith Ian T 4

Accession 0001225208-22-001307

CIK 0000885725other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 4:37 PM ET

Size

11.3 KB

Accession

0001225208-22-001307

Insider Transaction Report

Form 4
Period: 2022-02-01
Meredith Ian T
EVP/ Global Chief Medical Offi
Transactions
  • Tax Payment

    Common Stock

    2022-02-01$43.50/sh919$39,97730,839 total
  • Exercise/Conversion

    Deferred Stock Units

    2022-02-013,1310 total
    Exp: 2022-02-01Common Stock (3,131 underlying)
  • Exercise/Conversion

    Common Stock

    2022-02-01+3,13131,758 total
Footnotes (2)
  • [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F2]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 1, 2018, the first anniversary of the date of grant.

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

Entity typeother

Related Parties

1
  • filerCIK 0001693920

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:37 PM ET
Size
11.3 KB